Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

David Miles Meredith, M.D.,Ph.D.

Concepts

This page shows the publications David Meredith has written about Immunohistochemistry.
Connection Strength

0.746
  1. Distantly Metastatic Retinoblastoma to Soft Tissue and Bone: A Challenging Diagnosis Highlighting the Utility of CRX. Am J Surg Pathol. 2021 06 01; 45(6):820-824.
    View in: PubMed
    Score: 0.318
  2. Advances in Diagnostic Immunohistochemistry for Primary Tumors of the Central Nervous System. Adv Anat Pathol. 2020 May; 27(3):206-219.
    View in: PubMed
    Score: 0.295
  3. Chondromyxoid Fibroma Arising in Craniofacial Sites: A Clinicopathologic Analysis of 25 Cases. Am J Surg Pathol. 2018 03; 42(3):392-400.
    View in: PubMed
    Score: 0.063
  4. Immune profiling of pituitary tumors reveals variations in immune infiltration and checkpoint molecule expression. Pituitary. 2021 Jun; 24(3):359-373.
    View in: PubMed
    Score: 0.019
  5. Loss of histone H3 trimethylation on lysine 27 and nuclear expression of transducin-like enhancer 1 in primary intracranial sarcoma, DICER1-mutant. Histopathology. 2021 Jan; 78(2):265-275.
    View in: PubMed
    Score: 0.019
  6. The cellular distribution of the adenomatous polyposis coli tumour suppressor protein in neuroblastoma cells is regulated by microtubule dynamics. Neuroscience. 1997 Nov; 81(2):553-63.
    View in: PubMed
    Score: 0.016
  7. Expression of beta-catenin and the adenomatous polyposis coli tumour suppressor protein in mouse neocortical cells in vitro. Neurosci Lett. 1997 Oct 17; 235(3):129-32.
    View in: PubMed
    Score: 0.015
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.